06 Sep 2022 --- Researchers are exploring the effects of cannabidiol (CBD) on patients with heart disease as preclinical studies have been reviewed. The findings are said to be valid for cardiovascular outcomes in in-vivo studies with CBD, as some mechanisms found reduced oxidative stress and inflammation.
